OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
Oregon Health & Science University researchers. from left, Benjamin Burwitz, Ph.D., James Frank, Ph.D., Matthias Schabel, Ph.D., and Jamie Lo, M.D., M.C.R., have received a grant from the National Institutes of Health to investigate how cannabis use during pregnancy may affect pregnancy outcomes for pregnant people with HIV. (OHSU/Christine Torres Hicks)
OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
Oregon Health & Science University researchers. from left, James Frank, Ph.D., Benjamin Burwitz, Ph.D., Jamie Lo, M.D., M.C.R., and Matthias Schabel, Ph.D., have received a grant from the National Institutes of Health to investigate how cannabis use during pregnancy may affect pregnancy outcomes for pregnant people with HIV. (OHSU/Christine Torres Hicks)
OHSU awarded $6.7 million to study effects of cannabis use during pregnancy in people with HIV
Oregon Health & Science University researchers, from left, Matthias Schabel, Ph.D., James Frank, Ph.D., Jamie Lo, M.D., M.C.R., and Benjamin Burwitz, Ph.D., have received a grant from the National Institutes of Health to investigate how cannabis use during pregnancy may affect pregnancy outcomes for pregnant people with HIV. (OHSU/Christine Torres Hicks)
Un análisis de sangre detecta siete veces más cánceres que las pruebas de detección estándar
Blood test finds seven times more cancers than standard screenings
Un estudio de OHSU revela que las tasas de consumo de opioides durante el embarazo han aumentado más del doble
Rates of opioid use in pregnancy have more than doubled, OHSU study finds
Productos con cannabis con más THC reducen ligeramente el dolor, causan mayores efectos secundarios
Cannabis products with more THC slightly reduce pain, cause more side effects
Estudio: Resultados mixtos en el uso de ácido lipoico en el tratamiento de la esclerosis múltiple progresiva
La Dra. Rebecca Spain, M.S.P.H., es la autora principal de un nuevo ensayo aleatorio controlado clínico que prueba el suplemento de ácido lipoico de venta libre en el tratamiento de formas progresivas de esclerosis múltiple (EM). (OHSU/Christine Torres Hicks)
